Locations
As a truly global organization, we have operations in some 117 countries, including research, manufacturing, and corporate sites in the United States.
Corporate
Located in Center City Philadelphia, Franklin Plaza is one of two large corporate headquarters in the US. Along with the Research Triangle Park located in Raleigh-Durham NC, Franklin Plaza houses our marketing, communications, finance, IT, HR, sales, administration, and other corporate functions.

The Research Triangle Park campus, located between Raleigh and Durham, NC, is one of two large administrative headquarters in the US. The RTP campus is home to R&D facilities focused on metabolic and viral diseases, as well as microbials, musculoskeletal, and proliferate diseases. Along with Franklin Plaza in Philadelphia, RTP also houses sales and marketing, administrative, and corporate functions.

Research
Our molecular discovery research facility near Boston focuses on the early part of the drug discovery process

The Research and Development center at Upper Merion (PA) contains chemical and biotechnology pilot plants, the research and genetics group, and a significant development presence. The site is the hub for the cardiovascular and urogenital diseases Center of Excellence for Drug Discovery (CEDD), and a satellite for the microbial, musculoskeletal, and proliferative diseases; the respiratory, inflammation and respiratory pathogen and the metabolic and viral diseases CEDDs.

The research and development center at Upper Providence contains staff from medical (including data management), project management, product strategy, anti-infectives research, development, pharmaceutical technologies and chemical development, support, regulatory affairs and global marketing. The site will be the hub for the anti-bacterials & host defense CEDD and a satellite for the respiratory, inflammation & respiratory pathogens; and metabolic, bone & anti-virals CEDDs.

Biologicals
Hamilton is where we produce monophosphoryl lipid A (MPL), an adjuvant developed by Corixa. MPL is an essential ingredient in many of the new adjuvant systems developed by GSK Biologicals. We expect to increase Hamilton's production capacity soon, supplemented by a new building under construction at the Rixensart, Belgium site. The Hamilton site also carries out R&D.

This site is currently undergoing renovation and expansion to accommodate filling and lyophilization operations, and for developing a new cell culture-based flu vaccine.

Consumer
Our Consumer Healthcare Offices

Consumer manufacturing and R&D

Manufacturing
Consumer Healthcare Manufacturing




Regional Pharma Supply Manufacturing

Primary Supply Manufacturing



